UK Trends and Developments
Trends and Developments Contributed by: Amélie Chollet, Hannah Curtis and David Dennis CMS CMS understands that preparing for tomor- row’s challenges must start today, and adopts a future-facing approach, ensuring that its clients stay ahead in an ever-evolving landscape. The firm offers global expertise and local insights, with clients’ commercial goals always in mind. Industries can rapidly change, business models can be disrupted, and regulation can force or- ganisations to change course almost overnight; by continually scanning the horizon, CMS helps its clients to anticipate both challenges and op-
portunities. In a world where innovation is busi- ness as usual, the firm’s mission is to deliver practical, business-focused advice that helps clients of every size face the future with confi- dence. Its lawyers immerse themselves in their clients’ worlds, and as genuine experts in their fields offer a grasp of detail that is second to none. The firm combines this with a next-gener- ation mindset that means it can deliver innova- tive processes and solutions at speed.
Authors
Amélie Chollet is a partner in CMS’s life sciences and healthcare group, specialising in legal regulatory issues for life sciences companies in the UK and EU. With over 20 years of
Hannah Curtis is a partner in the technology and media team at CMS, and is a key member of the life sciences sector group. She advises across sectors, with a strong focus on life sciences
cross-border legal experience, she tackles complex regulatory challenges. Prior to CMS, Amélie was senior in-house counsel at major medical device companies for a decade, providing her with unique business insights. Her expertise covers product life cycle management, regulatory compliance, crisis management and due diligence. Focusing on medical device regulatory affairs, digital health technologies and horizontal regulatory frameworks, Amélie combines technical expertise with commercial pragmatism.
and healthcare, supported by her background in biological sciences. With nearly 20 years’ legal experience, she specialises in IP-rich transactions and commercial agreements, including licensing, R&D, manufacturing, collaborations and joint ventures. Hannah has completed secondments at the Wellcome Trust, Pfizer and the Nestlé Institute of Health Sciences, enhancing her deep sector insight and commercial acumen.
138 CHAMBERS.COM
Powered by FlippingBook